Total Visits

Views
Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis—what is best in class? Authors’ reply66

Total Visits Per Month

September 2023October 2023November 2023December 2023January 2024February 2024March 2024
Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis—what is best in class? Authors’ reply0005311

Top country views

Views
United States42
Poland4
United Kingdom3
Cyprus2
France2
Ireland2
Germany1
Greece1
Israel1
Iran1

Top cities views

Views
Louisville23
Boardman5
San Ramon5
Warsaw4
Dublin2
Limassol2
Ann Arbor1
Athens1
Costa Mesa1
Des Moines1